Today: 14 June 2026
Browse Category

Dividends 27 December 2025 - 29 December 2025

Fitell stock pops after $0.10 dividend, loyalty payout plan puts record dates in focus

Fitell stock pops after $0.10 dividend, loyalty payout plan puts record dates in focus

Fitell shares closed up 7.34% at $0.7299 Friday after announcing a $0.10 interim dividend and a shareholder loyalty payment program. The company set Dec. 29 as the loyalty program record date and Dec. 30 as the ex-dividend date. Shares last traded at $0.9307 after hours. Eligible shareholders must transfer shares into book-entry form by Dec. 29 to qualify for the loyalty payment.
29 December 2025
Singapore’s stock revival lifts IPO fundraising — and dividend hunters are chasing ThaiBev

Singapore’s stock revival lifts IPO fundraising — and dividend hunters are chasing ThaiBev

Singapore led Southeast Asia in IPO proceeds in 2025, with nine deals raising about $1.6 billion, according to Deloitte. The Monetary Authority of Singapore allocated S$3.95 billion to nine fund managers under a S$5 billion equity market program to boost liquidity. The Straits Times Index hit record highs, but market volumes fell from 38.6 billion shares in September to 29.3 billion in November.
29 December 2025
Medtronic (MDT) Stock Update: Dividend Timing, MiniMed IPO Catalyst, and What Investors Should Watch Before Monday’s Open

Medtronic (MDT) Stock Update: Dividend Timing, MiniMed IPO Catalyst, and What Investors Should Watch Before Monday’s Open

Medtronic (MDT) closed at $96.52 on the New York Stock Exchange after a slight pullback post-Christmas. No new company press releases appeared in the past 48 hours, though filings showed institutional activity and media highlighted Medtronic’s role in surgical robotics. The next $0.71 dividend is payable Jan. 16 to shareholders of record as of Dec. 26.
28 December 2025
Verizon Stock (VZ) Today: Dividend Clock, Frontier Deal Milestones, and Analyst Targets as Wall Street Heads Into a Holiday-Shortened Week

Verizon Stock (VZ) Today: Dividend Clock, Frontier Deal Milestones, and Analyst Targets as Wall Street Heads Into a Holiday-Shortened Week

Verizon shares closed at $40.48 on Friday, remaining in the low-$40s as investors assess a high dividend yield, leadership changes, and regulatory moves tied to its planned Frontier Communications acquisition. No major company press releases were issued over the weekend. Analysts are watching Verizon’s upcoming Jan. 30 earnings and recent institutional moves, including Cadinha & Co. cutting its stake last quarter.
Altria Stock (MO) News: Dividend Reset, FDA on! PLUS Authorization, and NJOY Legal Battle—What Investors Need Before Monday

Altria Stock (MO) News: Dividend Reset, FDA on! PLUS Authorization, and NJOY Legal Battle—What Investors Need Before Monday

Altria shares closed at $57.60 Friday, down 2.33% after the stock went ex-dividend for a $1.06 payout payable Jan. 9. After-hours trading showed little change, with MO near $57.64. The drop followed the ex-dividend adjustment and came as Altria notched a regulatory win for on! PLUS nicotine pouches and faced ongoing NJOY-Juul legal disputes.
28 December 2025
Banco Bradesco S.A. Stock (NYSE: BBD) Weekend Update: Dividend Catalyst, Brazil Rates, and Analyst Targets Ahead of Monday’s Open

Banco Bradesco S.A. Stock (NYSE: BBD) Weekend Update: Dividend Catalyst, Brazil Rates, and Analyst Targets Ahead of Monday’s Open

Banco Bradesco’s U.S.-listed ADRs closed Friday at $3.35 (preferred) and $2.93 (common), near the top of their 52-week range. No major company news emerged over the weekend. Investors are watching for Brazil macro developments and a R$3.9 billion “interest on equity” payout, with a record date of Dec. 29 and ex-date Dec. 30. Bradesco’s ADRs have nearly doubled since the start of 2025.
28 December 2025
AT&T Stock (NYSE: T) Weekend Update: Dividend Outlook, Analyst Targets, and What to Watch Before Monday’s Open

AT&T Stock (NYSE: T) Weekend Update: Dividend Outlook, Analyst Targets, and What to Watch Before Monday’s Open

AT&T closed Friday at $24.65, with investors focused on its dividend and cash flow ahead of Monday’s session. The company declared a quarterly dividend of $0.2775 per share, payable Feb. 2, 2026. Recent commentary highlights AT&T as a high-yield, defensive pick, though concerns about competition and regulation persist. AT&T’s market cap stands near $175 billion, with a 52-week range of $21.38 to $29.79.
28 December 2025
Banco Bradesco (BBD) Stock: Key Dividend Dates, Analyst Forecasts, and What to Watch Before Wall Street Reopens

Banco Bradesco (BBD) Stock: Key Dividend Dates, Analyst Forecasts, and What to Watch Before Wall Street Reopens

Bradesco’s U.S.-listed preferred ADR (BBD) closed Friday at $3.35, down 0.3%, as investors eyed a R$3.9 billion supplementary interest-on-equity payout. Shareholders on record Dec. 29 will qualify, with shares trading ex-right Dec. 30. The payout, detailed in a Dec. 18 SEC filing, will be paid by July 31, 2026, after 15% withholding tax. BBD ended the week near the top of its 52-week range.
28 December 2025
Bristol-Myers Squibb (BMY) Stock: What Investors Should Watch Before Monday’s Open as Dividend Date, Earnings, and 2026 Catalysts Come Into Focus

Bristol-Myers Squibb (BMY) Stock: What Investors Should Watch Before Monday’s Open as Dividend Date, Earnings, and 2026 Catalysts Come Into Focus

Bristol-Myers Squibb shares closed Friday at $54.65, little changed, and edged up to $54.72 after hours. The stock is down about 3% for 2025, trading near the lower end of its yearly range. Recent headlines focused on institutional position changes and year-end market conditions, with light news flow as U.S. markets head into the weekend.
AbbVie Stock (ABBV) Holds Near $230 as Year-End “Santa Rally” Takes Shape; Dividend Boost, Legal Headlines and 2026 Outlook in Focus

AbbVie Stock (ABBV) Holds Near $230 as Year-End “Santa Rally” Takes Shape; Dividend Boost, Legal Headlines and 2026 Outlook in Focus

AbbVie closed Friday at $229.98, near its 52-week high, as U.S. markets ended a quiet post-holiday session with major indexes little changed. No major AbbVie corporate news broke in the past two days, but investor analysis and institutional filings kept the stock in focus. Institutions and hedge funds hold about 70% of shares. The next regular trading session is Monday.
American Express Stock (AXP) Update: After-Hours Bounce, Analyst Targets, Dividend and Earnings Dates Ahead of Monday’s Session

American Express Stock (AXP) Update: After-Hours Bounce, Analyst Targets, Dividend and Earnings Dates Ahead of Monday’s Session

American Express closed Friday at $381.05, down 0.54%, with after-hours trading lifting shares to $383.75. The stock remains near its 52-week high of $387.49. About 1.11 million shares changed hands in light, post-holiday trading. Markets are closed for the weekend, with attention turning to next week’s Federal Reserve meeting minutes.
Altria Group Stock (MO) Slides After Ex-Dividend Session as Investors Track NJOY Legal Fight and FDA Green Light for on! PLUS Nicotine Pouches

Altria Group Stock (MO) Slides After Ex-Dividend Session as Investors Track NJOY Legal Fight and FDA Green Light for on! PLUS Nicotine Pouches

Altria shares fell 2.34% to $57.60 Friday as the stock traded ex-dividend, with the $1.06 per share payout set for Jan. 9. Juul Labs asked an Arizona judge to block Altria and NJOY from using documents uploaded to a UCSF database, arguing the records could affect a vape patent dispute. The broader market saw light trading and finished slightly lower.
27 December 2025
Philip Morris International Inc. (PM) Stock: Ex‑Dividend Reset, Options Buzz, and What Investors Should Watch Before Monday’s Open

Philip Morris International Inc. (PM) Stock: Ex‑Dividend Reset, Options Buzz, and What Investors Should Watch Before Monday’s Open

Philip Morris International shares closed at $161.05 Friday, down about 1%, after trading ex-dividend for a $1.47 quarterly payout. The drop aligned with the ex-dividend date of Dec. 26, when new buyers no longer qualify for the dividend. U.S. markets were closed Saturday. Trading volume was light in the post-holiday session.
27 December 2025
1 18 19 20 21 22 43

Stock Market Today

  • Indivior's Chief Scientific Officer Sells Shares Amid Stock Rally: Investor Implications
    June 14, 2026, 12:02 AM EDT. Christian Heidbreder, Chief Scientific Officer at Indivior Pharmaceuticals, sold 18,586 shares valued at $707,383 on June 11, 2026, representing 7.54% of his holdings. Post-sale, he retains 227,923 shares worth about $8.69 million, maintaining a 0.18% stake. The sale occurred during a significant stock price surge, with Indivior shares rising 177% over the past year, reflecting strong market performance amid growth in opioid dependence therapies. The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan, not signaling insider concerns. Indivior's strategy focuses on buprenorphine-based addiction treatments, with $1.29 billion in trailing twelve-month revenue and $252 million net income, underscoring its established market position and ongoing research-led expansion.

Latest articles

Kraft Heinz Shares Rally for Six Days—Is KHC a Buy Now?

Kraft Heinz Shares Rally for Six Days—Is KHC a Buy Now?

14 June 2026
Kraft Heinz closed up 0.70% at $24.39, outpacing the S&P 500, as investors weighed its 6.6% dividend yield against falling organic sales, lower adjusted earnings, and cautious analyst targets; the next earnings update is seen as the key test for whether $600 million in marketing and R&D can revive growth and support the stock’s rebound.
Go toTop